Physician profile
Michael James Gilbert
NPI 1932596988
$2,731.83
in general payments reported to CMS, 2019-2025
13 companies · $583 in 2025
The $583 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2021: $543 · 2022: $268 · 2023: $670 · 2024: $186 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,439.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $651.66 | 2021-2024 | Tecnis Iol, Baerveldt Glaucoma Implant (250), Whitestar Phaco Handpiece |
| Alcon Vision LLC | $507.94 | 2019-2025 | Clareon Panoptix Pro, Rocklatan, Tryptyr |
| Edwards Lifesciences Corporation | $498.04 | 2021-2022 | |
| Glaukos Corporation | $202.60 | 2023-2024 | Idose |
| Rxsight INC | $164.80 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Biotissue Holdings INC. | $163.79 | 2025 | |
| Bausch & Lomb Americas INC. | $120.71 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Regeneron Healthcare Solutions, INC. | $112.20 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $106.88 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $97.40 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $60.85 | 2024-2025 | Xdemvy |
| Astellas Pharma US INC | $28.78 | 2025 | Izervay |
| Genentech USA, INC. | $16.18 | 2023 | Vabysmo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.